Zimmer Biomet
ZBH · NYSE
Bulios Fair Price
$66.81
32.1% downside
Current Price
$98.39
According to Bulios Fair Price, ZBH is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Zimmer Biomet Holdings, Inc. (ZBH) is an American company specializing in the manufacturing and distribution of medical devices and implants for orthopedics, traumatology, and other medical fields. The company provides a wide range of products, including artificial joints, bone implants, surgical instruments, and bioresorbable materials for the treatment of patients with orthopedic issues. Zimmer Biomet is a respected leader in the healthcare technology industry and contributes to advancements in treatment procedures and patient care. The company collaborates with medical professionals and research institutions to ensure the highest quality and safety of its products. Zimmer Biomet focuses on innovation and the development of new technologies that bring better outcomes and longer implant lifespan for doctors and patients. Its products are sought after and utilized in healthcare facilities worldwide. Shares of Zimmer Biomet Holdings, Inc. (ZBH) could represent an intriguing investment opportunity for those who believe in the growing demand for orthopedic medical devices and the benefits of modern healthcare technologies.
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos
Employees
17,000
Headquarters
Warsaw
Upcoming events
Ex-Dividend
Ex-dividend date
Dividend Payment
Payment date
Earnings
Upcoming earnings report